THERYQ
Nathalie Chadeau has an extensive background in medical sales and clinical management, with a focus on radiation oncology, infectious diseases, and other medical specialties. Currently serving as the Global Clinical Director at THERYQ, Nathalie oversees FlashRT clinical development for THERYQ systems. Prior to this role, Nathalie held various positions at Accuray, Sanofi, Roche, SmithKline Beecham Corporation, and Laboratoire Debat, where Nathalie gained experience in market sales, KOL engagement, and medical affairs. Nathalie holds degrees in medical affairs, management, communication, infectious diseases, and sales.
This person is not in any teams
This person is not in any offices
THERYQ
THERYQ is an innovative medical device company specializing in the design, manufacture and commercialization of FLASH radiotherapy systems. THERYQ aims to expand the use of radiotherapy in oncology and unlock new treatments for patients with cancer. We want to improve patient care and have a positive impact on patients' lives, expectancies, and quality of life by providing efficient, precise, ultra-short radiation treatments. FLASH radiotherapy offers new possibilities and hope for cancer patients all over the world.